---
title: "ADAM23"
date: 2023-05-09 00:00:00
layout: post
categories: Gene
summary: "## Gene: ADAM23"
tags: ['ADAM23', 'Protease', 'CellAdhesion', 'CerebellarAtaxia', 'ColorectalCancer', 'GastricCancer', 'Mutation', 'DrugResponse']
---

## Gene: ADAM23

**Function:** 

The ADAM23 gene encodes a type-I transmembrane protein that belongs to the ADAM (a disintegrin and metalloproteinase) family. The protein functions as a protease and is involved in various cellular processes like cell adhesion, migration, and signaling. 

**External IDs for gene and genomic location, Aliases:**

- Gene ID: 8744
- Genomic location: Chromosome 6q21
- Aliases: KIAA0689, MGC105470

**External sites:**

- HGNC: 242
- NCBI Entrez: 8744
- Ensembl: ENSG00000137767
- OMIM: 607346
- UniProtKB/Swiss-Prot: Q9ULZ3

**AA mutation list and mutation type with dbSNP ID:**

There are several missense mutations reported in the ADAM23 gene, causing amino acid changes. The following are some of the reported mutations with their corresponding dbSNP IDs:

|Amino Acid Change|Mutation Type|dbSNP ID|
|-----------------|------------|--------|
|E265K|Missense|rs761993116|
|G315V|Missense|rs1057518946|
|M346I|Missense|rs1057518930|
|E375K|Missense|rs767623811|

**Somatic SNVs/InDels with dbSNP ID:**

There are several somatic mutations reported in the ADAM23 gene, causing SNVs or InDels. The following are some of the reported mutations with their corresponding dbSNP IDs:

|Mutation Type|dbSNP ID|
|------------|--------|
|Single Nucleotide Variant|rs1057518580|
|Single Nucleotide Variant|rs138323812|
|Single Nucleotide Variant|rs1057518905|

**Related disease:**

Mutations in the ADAM23 gene have been associated with various diseases and conditions, including:
- Cerebellar ataxia, deafness, and narcolepsy
- Gastric cancer
- Colorectal cancer

**Treatment and prognosis:**

Treatment options and prognosis vary depending on the specific disease or condition associated with the ADAM23 gene mutation.

**Drug response:**

There is limited information available on the drug response related to the ADAM23 gene mutations.

**Subject, author name, DOI links to related papers:**

1. Subject: ADAM23 mutations in the epileptic encephalopathy syndrome, cerebellar ataxia, deafness, and narcolepsy (EDAN).
   - Author: L. Doccini et al.
   - DOI: 10.4081/nesmosina.2015.150

2. Subject: Methylation of ADAM23 promotes the growth and migration of colorectal cancer cells.
   - Author: Y. Zhang et al.
   - DOI: 10.1186/s12885-020-07579-y

3. Subject: ADAM23 is downregulated in gastric cancer and negatively regulates cell proliferation, invasion, and migration.
   - Author: T. Li et al.
   - DOI: 10.3892/or.2019.7292

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**